Our
BUSINESS LINES
We enter the Life Sciences through our complementary and interconnected businesses: animal breeding & bioproductions, vaccines, and innovative proteins.
Genetic selection and bioproductions
WHAT IS GENETIC
SELECTION?
Since animals were first domesticated and breeding began more 10,000 years ago, Humans have noticed that mating animals with the highest levels of strength, quality or output quantity would help them to achieve positive developments in your flocks. Their descendants provided better breeding results and helped humans to feed their communities better.
This principle of selecting the best individuals based on the criteria of animal health, productivity, output quality and ease of breeding management provides the basis for our genetic selection business line.
While this approach (which is identical to the one for plant-based fields), has remained the same for more than 10,000 years, our knowledge and expertise have moved on a lot. Genetic selection is still playing a role in providing better food and nutrition around the world, by providing better access to animal proteins, which are essential to Human Health.
bioproductions
We support Human Health through our Bioproductions business as a supplier of fundamental elements for the manufacture of essential medicines such as embryonated eggs (used to make inactivated vaccines).
These products are considered to be among the most effective in the world for their properties in the treatment of rare and life-threatening diseases.
AS CLOSE TO NATURE
AS POSSIBLE
“Life Sciences at the heart of our selection”
Thanks to cutting-edge technology combined with knowledge from the world’s leading genetics experts:
- We are taking closer looks at Nature’s mechanisms in order to select the “champion” animals.
- We are also putting together mating plans for these animals through selection programmes, through natural methods or insemination.
- As a result, we are strengthening the gene pool for future generations.
Groupe Grimaud has committed to protecting animal biodiversity both in its selection programmes and in species conservation programmes, in partnership with INRAE (National Research Institute for Agriculture, Food and Nutrition, and Ecology).
ONE LIFE
Better access to animal protein throughout the world is essential for reducing malnutrition and famine, but is by no means the only criteria for improving Human Health.
We are quite confident that Human well-being is interconnected with and inseparable from that of Animals and the Planet and are committed to improving this global well-being:
Human Health, Animal Health, Biodiversity, better natural infection resistance, optimising the use of natural resources through feed conversion rates (conversion ratios), respect for animals’ natural behaviours and better animal welfare are just some of the many criteria that provide the basis for the genetic selection programmes that we have undertaken.
The GENETECH
Research platform
Groupe Grimaud is known throughout the world for the success and innovation of its Research & Development.
This is built on a multi-species Research platform which enables our 30 animal researchers and experts, biologists and statisticians to share their knowledge and expertise. As a result, we pool together investment programmes in order to acquire and get to grips with the latest technologies.
Our subsidiaries
Partner companies
Vaccines
Human
Biopharmacy
At the heart of Human Health, we invest in research programmes to develop highly promising vaccines against Lyme disease, chikungunya and Covid19 as the main shareholder of Valneva (listed on Euronext & Nasdaq).
Animal
Biopharmacy
Our support for the trio of Human Health, Animal Health and the Wellbeing of the Planet led us to set up the company Filavie in 2000, which develops vaccines aimed at livestock and domestic animals, as well as alternative-medicine solutions (helping the fight against antibiotic resistance).
Our subsidiaries
Partner companies
Innovative proteins
Innovative
proteins
By 2040, conventional animal production alone will not be able to meet the food needs of the world's growing population. It is therefore necessary to open up complementary production methods that are economical with natural resources.
Insect proteins for animal or human food, plant protein or even cultivated animal protein: the future good protein energy mix will be innovative, sustainable and complementary to conventional animal proteins.
Not instead of, but in addition to!
Insect
proteins
Feeding insect meal to animals is an effective way to improve the sustainability of livestock production by providing a carbon-neutral input.
Black soldier fly larvae are particularly interesting for this purpose. By feeding on human food co-products (beet pulp, brewery grains, etc.), they can convert 60% of organic waste into protein. A very efficient bioconverter, their weight is multiplied by 10,000 in just 12 days!
The insect-based protein meal also provides significant nutritional added value in animal feed.
In partnership with Nasekomo (zootechnical expert in Black Soldier Fly breeding), we have created "Fly Genetics": the first company in the world specialised in insect genetic selection.
Thanks to its genetic selection programmes, Fly Genetics is close to the insect industry to enable them to increase the efficiency of bioconversion, reduce zootechnical costs and harmonise production flows.
Vital Meat, a cellular agriculture
project
Animal cell culture is a new source of protein to complement conventional meat.
Cultured meat is not intended to replace any other type of existing production, but to create a new solution to meet the societal expectations of a growing part of the world's population.
Groupe Grimaud, promoter of animal proteins essential to a balanced diet, also wishes to be a forerunner in this new production method and to have different answers for different consumer expectations.
Based in France and initiating its activity by offering cultivated chicken, the company Vital Meat aims to become the leading technological platform in the production of cultivated animal proteins.
NATURAL CONCEPT
A world
in better health
In 2009, Groupe Grimaud and its subsidiaries committed to a continuous improvement strategy in order to help to ensure a balance within the Living World between Humans, Animals and Plants.
By creating the “Natural Concept” initiative, our operations divisions are committed to and are working towards ensuring that the world is in a healthier state:
1. Feeding the world in an eco-friendly way
2. Supporting measures by the animal fields to improve food, nutrition and human health
3. Marrying performances in the fields of production and sustainability
4. Tapping into Biology and Life Sciences as levers for action in order to meet these challenges
5. Embarking on an improvement initiative
Buoyed by this commitment, each year, the strategy includes more than 200 professionals, teachers, students and Livestock professionals as part of a day focussing on improving Human Health, which is interconnected with the health of animals and the Planet.
